Clinical Trial: Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883421) titled 'Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore' on Oct. 13.

Brief Summary: The goal of this clinical trial is to learn if the high-dose influenza vaccine can improve year-round protection in older adults aged 60 years and above. The main question it aims to answer is:

* Can the high-dose influenza vaccine induce higher antibody titres at Day 14 post-vaccination compared to standard-dose influenza vaccine?

Participants will:

* Receive one dose of either the high-dose or standard-dose influenza vaccine

* Be followed for one year, with four scheduled visits

* Keep a diary of their ...